Join us as KGI faculty members interview biotech and healthcare industry leaders to discuss infectious diseases, pandemic response, and COVID-19! The series will be held Wednesdays from June 17 to August 5. This virtual speaker series is open to:
Share this page with friends and colleagues: kgi.edu/summerseries!
Watch the Replay on Facebook
KGI President Sheldon Schuster interviewed Kiran Mazumdar-Shaw, Executive Chairperson and Managing Director of Biocon Limited, a globally recognized biopharmaceuticals company in India and the country’s leading biotech enterprise. Ms. Mazumdar-Shaw is a pioneer of the biotech industry in India and is recognized as a global thought leader. She is ranked among the “World’s 25 Most Influential People in Biopharma” by Fierce Biotech, Forbes Magazine’s “World’s 100 Most Powerful Women,” Fortune’s “Top 25 Most Powerful Women in Asia-Pacific,” and TIME Magazine’s “100 Most Influential People” in the world. Don’t miss this opportunity to learn from our distinguished guest!
KGI’s Sue Behrens interviewed Dr. Dafni Bika, Global Head of Pharmaceutical Technology and Development at AstraZeneca. Dr. Bika has more than 25 years of experience in pharmaceutical development and manufacturing science and technology, working for companies such as Merck and Bristol-Myers Squibb before moving to AstraZeneca. She leads global teams in designing, developing, and commercializing new products and develops and introduces new manufacturing technologies.
Bika has an MS in Materials Science and Engineering from the University of Rochester, and a PhD in Materials Science and Engineering from the University of Pennsylvania.
KGI School of Pharmacy and Health Sciences Dean Martin Zdanowicz interviewed Dr. David Lawrence, Dean of the KGI School of Medicine and former CEO and Chairman of the Kaiser Foundation Health Plan and Hospitals. Prior to joining Kaiser Permanente, Lawrence worked in Public Health and Human Services in Multnomah County, OR; on the faculty of the University of Washington School of Public Health and Community Medicine and the School of Medicine; as an advisor to the Ministry of Health of Chile; and as a Peace Corps Physician in the Dominican Republic and Washington, DC.
He is the author of From Chaos to Care: The Promise of Team-Based Medicine (Perseus, 2002). His book, Best Care; Best Future: A Guide For Healthcare Leaders (Second River Publishing, 2014), received the “2015 Book of the Year” award from the American College of Healthcare Executives.
This event featured a virtual interview with Brian Hill, Director of Supply Chain at Gilead Sciences. Hill has years of experience in the biotechnology industry, previously holding high-level positions at such companies as AbbVie and Abbott Labs. Hill holds a BS in Chemistry from the University of Illinois at Urbana-Champaign.
KGI’s Rajesh Parti interviewed Dr. Steven Galson, Senior Vice President of Global Regulatory Affairs and Safety at Amgen. Dr. Galson has more than 20 years of experience in government service, including two years as acting Surgeon General of the United States. Previously, he served as director of the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER), where he provided leadership for the center’s broad national and international programs in pharmaceutical regulation.
Dr. Galson began his Public Health Service (PHS) career as an epidemiological investigator at the Centers for Disease Control and Prevention (CDC). He also held senior-level positions at the Environmental Protection Agency (EPA); the Department of Energy, where he was chief medical officer; and the Department of Health and Human Services. Galson is a member of the Clinical Trials Transformation Initiative Executive Committee, a trustee on the PHS Commissioned Officers Foundation, and on the board of trustees for KGI. Don’t miss this opportunity to learn from our distinguished guest!
In this event, KGI Professor Animesh Ray interviewed a panel of professional data scientists. The data scientists are from companies that are members of an industry group called PHUSE, a global community of professionals passionate about the advancement of clinical information. PHUSE has expanded from its roots as a conference for European statistical programmers to a global membership organization and platform for the discussion of topics encompassing the work of data managers, biostatisticians, statistical programmers, and eClinical IT professionals.
The panelists for this event included:
In this event, KGI Dean of Research Larry Grill interviewed David Robinson, Deputy Director, CMC Vaccines Development and Surveillance at the Bill & Melinda Gates Foundation. Dr. Robinson and his team work with internal and external partners to develop and execute CMC strategies and harness advances in science and technology that enable vaccine development to save lives in developing countries. Dr. Robinson has 25 years experience in global vaccine and biologics product commercialization, process development, and CMC regulatory strategy and execution. He received his bachelor’s degree in chemical engineering from UC Berkeley, his PhD from MIT, and did his postdoctoral research at the Swiss Federal Institute of Technology (ETH).
Register for free
Time: 12 p.m. to 1 p.m. PDT
Come join us for a virtual interview with Dr. Lisa Purcell, Senior Manager, Clinical Sciences, Immunology and Inflammation, and Dr. Alina Baum, Senior Staff Scientist, both at Regeneron Pharmaceuticals.
Lisa Purcell joined Regeneron in 2008 and is a Clinical Scientist in Immunology and Inflammation. She received her PhD from McGill University and completed her Postdoctoral Training at Columbia University. Dr. Purcell’s current work focuses on the clinical development of therapies within the immunology and infectious disease therapeutic areas, including those for SARS-CoV-2/COVID-19. She has also developed therapies for pathogens using Regeneron’s novel technologies. Dr. Purcell is the scientific director of Regeneron’s science education efforts, including the Regeneron Science Talent Search, research mentorship efforts, the International and Westchester Science and Engineering Fair, and STEM teacher programs.
Alina Baum is a Senior Staff Scientist at Regeneron Pharmaceuticals where she is leading the COVID-19 spike antibody program currently in clinical trials. She received her PhD in molecular virology from the lab of Adolfo Garcia-Sastre at Mount Sinai School of Medicine and performed postdoctoral studies with Charlie Rice at Rockefeller University. Her academic career focused on studying interactions between RNA viruses and the innate immune system. In her current position at Regeneron, she is leading a virology research group developing novel therapies for viral infections including influenza and hepatitis B, and emerging pathogens such as Ebola and SARS-CoV-2, as well as the development of oncolytic viruses and vaccines for cancer immunotherapy.
Don’t miss this opportunity to learn from our distinguished guest!